Indeed, marked elevation of heart failure markers such as brain natriuretic peptide (BNP), fatty acid-binding protein 3 (FABP3), and creatine kinase (CK) in SMA patients suggests that normal cardiac function may require sufficient functional expression of SMN. The gene discussed is FABP3; the disease is heart failure.